HD-OPM Archive
Hashtags

#semaglutide

14 posts

Semaglutide cut inflammation 38% in SELECT; biggest drops tracked with fewer events

Aug 21, 2026 · Louis Nervegna ♥ 20 · 💬 4 GLP-1 drugs (semaglutide, tirzepatide)

A new analysis of the SELECT trial asks why semaglutide reduced cardiovascular events. Inflammation markers fell 38% versus placebo, early and even in people who lost little weight, and those with the biggest drops had the fewest events. Modelling suggests part of the drug's benefit runs through lower inflammation, though this shows a link rather than proof of cause.

ARPA-H PROSPR program ($144M) funds first phase 3 aging trials of three drugs

May 20, 2026 · Louis Nervegna ♥ 9 Aging & longevity

Eric Verdin's shared post says ARPA-H awarded $144 million to seven teams to lay groundwork for human aging trials, including a phase 3 in healthy adults in their 60s testing rapamycin, an SGLT2 inhibitor and semaglutide. The key gap is a validated aging biomarker regulators accept. Louis adds that age is the biggest CVD risk factor.

Semaglutide extended elderly female mouse lifespan 12%; calorie restriction already known

Sep 14, 2026 · Louis Nervegna ♥ 5 GLP-1 drugs (semaglutide, tirzepatide)

A shared Nature study report says elderly female mice on semaglutide lived 12% longer and improved on aging hallmarks, matching or beating caloric restriction on several measures. Louis notes calorie restriction slowing aging in animals is well established. The caveats: inbred female mice, possible muscle loss in older people, and no human data.

Semaglutide REMODEL trial: 40% less albuminuria, and a calorie-restriction interpretation

Oct 01, 2026 · Louis Nervegna ♥ 1 GLP-1 drugs (semaglutide, tirzepatide)

A Nature Medicine mechanistic study (REMODEL) found semaglutide in people with type 2 diabetes and chronic kidney disease cut albuminuria by 40% and reduced kidney and perirenal fat, with biopsy changes in glomerular endothelial cells. The poster argues the kidney benefit stems from negative energy balance rather than anything special about GLP-1 drugs, which simply make calorie restriction easier.